Loading…
Reported covered position: Sr. Advisor, Office of the Asst. Secretary for Legislation, US Dept. of Health & Human Services; Sr. Legislative Asst, US Rep. Vicky Hartzler; Legislative Aide, US Senator Deb Fischer; Legislative Aide, US Rep. John R. Carter
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Diagnostic test reimbursement and policies; Proposals related to newborn screening; Proposals related to pandemic preparedness; H.R. 8882, To amend the Internal Revenue Code of 1986 to treat amounts paid for private umbilical cord blood, or umbilical cord tissue, banking services as medical care expenses
COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain H.R. 8882, To amend the Internal Revenue Code of 1986 to treat amounts paid for private umbilical cord blood, or umbilical cord tissue, banking services as medical care expenses
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
REVVITY, INC. via REVVITY, INC.
2025 · first_quarter · Q1
Diagnostic test reimbursement and policies; Proposals related to newborn screening; Proposals related to pandemic preparedness; H.R. 8882, To amend the Internal Revenue Code of 1986 to treat amounts paid for private umbilical cord blood, or umbilical cord tissue, banking services as medical care expenses
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REVVITY, INC. via REVVITY, INC.
2024 · fourth_quarter · Q4
Source: Senate LDA
COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain H.R. 8882, To amend the Internal Revenue Code of 1986 to treat amounts paid for private umbilical cord blood, or umbilical cord tissue, banking services as medical care expenses
COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain H.R. 8882, To amend the Internal Revenue Code of 1986 to treat amounts paid for private umbilical cord blood, or umbilical cord tissue, banking services as medical care expenses
COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain H.R. 8882, To amend the Internal Revenue Code of 1986 to treat amounts paid for private umbilical cord blood, or umbilical cord tissue, banking services as medical care expenses
COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain H.R. 8882, To amend the Internal Revenue Code of 1986 to treat amounts paid for private umbilical cord blood, or umbilical cord tissue, banking services as medical care expenses
COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain H.R. 8882, To amend the Internal Revenue Code of 1986 to treat amounts paid for private umbilical cord blood, or umbilical cord tissue, banking services as medical care expenses
COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain H.R. 1170 Access to Future Cures Act, proposals related to expenses for storage of blood or biomaterial derived from blood
COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain H.R. 1170 Access to Future Cures Act, proposals related to expenses for storage of blood or biomaterial derived from blood
COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain H.R. 1170 Access to Future Cures Act, proposals related to expenses for storage of blood or biomaterial derived from blood
COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain H.R. 1170 Access to Future Cures Act, proposals related to expenses for storage of blood or biomaterial derived from blood
COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain H.R. 1170 Access to Future Cures Act, proposals related to expenses for storage of blood or biomaterial derived from blood
COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain H.R. 1170 Access to Future Cures Act, proposals related to expenses for storage of blood or biomaterial derived from blood
United States Innovation and Competition Act of 2021
Client: REVVITY, INC. · Firm: REVVITY, INC.
Proposals related to S.1260, the United States Innovation and Competition Act of 2021
United States Innovation and Competition Act of 2021
Client: REVVITY, INC. · Firm: REVVITY, INC.
Proposals related to S.1260, the United States Innovation and Competition Act of 2021.
United States Innovation and Competition Act of 2021
Client: REVVITY, INC. · Firm: REVVITY, INC.
Proposals related to S.1260, the United States Innovation and Competition Act of 2021
United States Innovation and Competition Act of 2021
Client: REVVITY, INC. · Firm: REVVITY, INC.
Proposals related to S.1260, the United States Innovation and Competition Act of 2021.
American Rescue Plan implementation COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain
American Rescue Plan implementation COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain
American Rescue Plan implementation COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain COVID-19 preparedness products and services Diagnostic test reimbursement and policies
American Rescue Plan implementation COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain Proposals related to pandemic preparedness
American Rescue Plan implementation COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
American Rescue Plan implementation COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 4128 VALID (Verifying Accurate Leading�edge IVCT Development) Act of 2021 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain
Diagnostic test reimbursement and policies COVID-19 preparedness products and services American Rescue Plan implementation Proposals related to preserving medical supply chain Proposals related to COVID-19 medical device regulation Proposals related to newborn screening H.R. 6102 VALID (Verifying Accurate Leading�edge IVCT Development) Act of 2020
American Rescue Plan implementation COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading�edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain
United States Innovation and Competition Act of 2021
Client: REVVITY, INC. · Firm: REVVITY, INC.
Proposals related to S.1260, the United States Innovation and Competition Act of 2021
United States Innovation and Competition Act of 2021
Client: REVVITY, INC. · Firm: REVVITY, INC.
Proposals related to S.1260, the United States Innovation and Competition Act of 2021
United States Innovation and Competition Act of 2021
Client: REVVITY, INC. · Firm: REVVITY, INC.
Proposals related to S.1260, the United States Innovation and Competition Act of 2021
COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain H.R. 8882, To amend the Internal Revenue Code of 1986 to treat amounts paid for private umbilical cord blood, or umbilical cord tissue, banking services as medical care expenses
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REVVITY, INC. via REVVITY, INC.
2024 · third_quarter · Q3
COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain H.R. 8882, To amend the Internal Revenue Code of 1986 to treat amounts paid for private umbilical cord blood, or umbilical cord tissue, banking services as medical care expenses
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REVVITY, INC. via REVVITY, INC.
2024 · second_quarter · Q2
COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain H.R. 8882, To amend the Internal Revenue Code of 1986 to treat amounts paid for private umbilical cord blood, or umbilical cord tissue, banking services as medical care expenses
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REVVITY, INC. via REVVITY, INC.
2024 · first_quarter · Q1
COVID-19 preparedness products and services Diagnostic test reimbursement and policies Proposals related to regulation of in vitro diagnostics Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain Proposals related to expenses for storage of blood or biomaterial derived from blood
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REVVITY, INC. via REVVITY, INC.
2023 · fourth_quarter · Q4
COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain H.R. 1170 Access to Future Cures Act, proposals related to expenses for storage of blood or biomaterial derived from blood
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REVVITY, INC. via REVVITY, INC.
2023 · third_quarter · Q3
COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain H.R. 1170 Access to Future Cures Act, proposals related to expenses for storage of blood or biomaterial derived from blood
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REVVITY, INC. via REVVITY, INC.
2023 · second_quarter · Q2
COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain H.R. 1170 Access to Future Cures Act, proposals related to expenses for storage of blood or biomaterial derived from blood
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REVVITY, INC. via REVVITY, INC.
2023 · first_quarter · Q1
COVID-19 preparedness products and services Diagnostic test reimbursement and policies Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain Proposals related to umbilical cord blood banking
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REVVITY, INC. via REVVITY, INC.
2022 · fourth_quarter · Q4
American Rescue Plan implementation COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain COVID-19 preparedness products and services Diagnostic test reimbursement and policies
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
REVVITY, INC. via REVVITY, INC.
2022 · third_quarter · 3A
Proposals related to S.1260, the United States Innovation and Competition Act of 2021.
Water Quality policies.
American Rescue Plan implementation COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REVVITY, INC. via REVVITY, INC.
2022 · third_quarter · Q3
American Rescue Plan implementation COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain
Proposals related to S.1260, the United States Innovation and Competition Act of 2021.
Water Quality policies
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REVVITY, INC. via REVVITY, INC.
2022 · second_quarter · Q2
American Rescue Plan implementation COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain Proposals related to pandemic preparedness
Proposals related to S.1260, the United States Innovation and Competition Act of 2021
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REVVITY, INC. via REVVITY, INC.
2022 · first_quarter · Q1
Proposals related to S.1260, the United States Innovation and Competition Act of 2021
American Rescue Plan implementation COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading‐edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REVVITY, INC. via REVVITY, INC.
2021 · first_quarter · RA
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood and tissue collection and storage payment policies; Pandemic preparedness and prevention policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood and tissue collection and storage payment policies; Pandemic preparedness and prevention policies.
REVVITY, INC. via REVVITY, INC.
2021 · fourth_quarter · Q4
American Rescue Plan implementation COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 6102 VALID (Verifying Accurate Leading�edge IVCT Development) Act of 2020 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain
Proposals related to S.1260, the United States Innovation and Competition Act of 2021
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REVVITY, INC. via REVVITY, INC.
2021 · third_quarter · Q3
American Rescue Plan implementation COVID-19 preparedness products and services Diagnostic test reimbursement and policies H.R. 4128 VALID (Verifying Accurate Leading�edge IVCT Development) Act of 2021 Proposals related to COVID-19 medical device regulation Proposals related to newborn screening Proposals related to preserving medical supply chain
Proposals related to S.1260, the United States Innovation and Competition Act of 2021
American Jobs Plan Water Quality policies
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REVVITY, INC. via REVVITY, INC.
2021 · second_quarter · Q2
Proposals related to S.1260, the United States Innovation and Competition Act of 2021
Water quality policies
Diagnostic test reimbursement and policies COVID-19 preparedness products and services American Rescue Plan implementation Proposals related to preserving medical supply chain Proposals related to COVID-19 medical device regulation Proposals related to newborn screening H.R. 6102 VALID (Verifying Accurate Leading�edge IVCT Development) Act of 2020
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REVVITY, INC. via REVVITY, INC.
2021 · first_quarter · Q1
Water quality policies American Jobs Plan
Diagnostic test reimbursement and policies COVID-19 preparedness products and services American Rescue Plan implementation Proposals related to preserving medical supply chain Proposals related to COVID-19 medical device regulation Proposals related to newborn screening
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REVVITY, INC. via REVVITY, INC.
2021 · first_quarter · RR
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood and tissue collection and storage payment policies; Pandemic preparedness and prevention policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood and tissue collection and storage payment policies; Pandemic preparedness and prevention policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood and tissue collection and storage payment policies; Pandemic preparedness and prevention policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood and tissue collection and storage payment policies; Pandemic preparedness and prevention policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood and tissue collection and storage payment policies; Pandemic preparedness and prevention policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood and tissue collection and storage payment policies; Pandemic preparedness and prevention policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood and tissue collection and storage payment policies; Pandemic preparedness and prevention policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood and tissue collection and storage payment policies; Pandemic preparedness and prevention policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood and tissue collection and storage payment policies; Pandemic preparedness and prevention policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood and tissue collection and storage payment policies; Pandemic preparedness and prevention policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies. Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; FDA Medical Device Product policies; The Family Cord Blood Banking Act and cord blood and tissue collection and storage payment policies; Pandemic preparedness and prevention policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.
SARS-CoV-2 Testing, including RT-PCR Testing, Rapid Antigen Testing, Genomic Sequencing, and T Cell Immune Response Testing, and related reimbursement and policies H.R. 1319, American Rescue Plan Act implementation, SARS-CoV-2 testing provisions; Newborn Screening Saves Lives Reauthorization Act; Recommended Uniform Screening Panel; Food safety and quality testing; Lift America Act, water and environmental quality testing provisions; FDA Medical Device Product policies.